These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 985563

  • 21. Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by beta-carboline alkaloids occurring in foods and plants.
    Herraiz T, Chaparro C.
    J Chromatogr A; 2006 Jul 07; 1120(1-2):237-43. PubMed ID: 16386263
    [Abstract] [Full Text] [Related]

  • 22. Effect of beta-propiolactone and beta-nitropropionic acid on rat brain monoamine oxidase.
    Mohammed YS, Mahfouz MM, Osman MY.
    Biochem Pharmacol; 1977 Jan 01; 26(1):62-3. PubMed ID: 831726
    [No Abstract] [Full Text] [Related]

  • 23. Effects of monoamine oxidase inhibitors on the borohydride stabilizable binding of serotonin and tryptamine in brain.
    Ungar F, Callaghan OH.
    Res Commun Chem Pathol Pharmacol; 1977 Jun 01; 17(2):191-9. PubMed ID: 877408
    [Abstract] [Full Text] [Related]

  • 24. Biosensor based on inhibition of monoamine oxidases A and B for detection of β-carbolines.
    Radulescu MC, Bucur MP, Bucur B, Radu GL.
    Talanta; 2015 May 01; 137():94-9. PubMed ID: 25770611
    [Abstract] [Full Text] [Related]

  • 25. An effect of monoamine oxidase inhibitors on brain serotonin of mice in addition to that resulting from inhibition of monoamine oxidase.
    DUBNICK B, LEESON GA, PHILLIPS GE.
    J Neurochem; 1962 May 01; 9():299-306. PubMed ID: 13888045
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells.
    Santillo MF, Liu Y, Ferguson M, Vohra SN, Wiesenfeld PL.
    Toxicol In Vitro; 2014 Apr 01; 28(3):403-10. PubMed ID: 24373881
    [Abstract] [Full Text] [Related]

  • 27. Tryptoline inhibition of serotonin uptake in rat forebrain homogenates.
    Keller KJ, Elliott GR, Holman RB, Vernikos-Danellis J, Barchas JD.
    J Pharmacol Exp Ther; 1976 Sep 01; 198(3):619-25. PubMed ID: 978463
    [Abstract] [Full Text] [Related]

  • 28. [Importance of the initial monoamine oxidase activity for the development of the activating or inhibiting action of indolylhydrazides].
    Safrazbekian RR, Sukasian RS, Arzanunts EM.
    Vopr Med Khim; 1979 Sep 01; 25(3):311-4. PubMed ID: 452498
    [Abstract] [Full Text] [Related]

  • 29. [Inhibitory effects of the extract of pilose antler on monoamine oxidase in aged mice].
    Chen X, Jia Y, Wang B.
    Zhongguo Zhong Yao Za Zhi; 1992 Feb 01; 17(2):107-10, 128. PubMed ID: 1418524
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the inhibitory effects of propargylamine and pargyline on brain and liver monoamine oxidase activity.
    Abeles RH, Tashjian AH.
    Biochem Pharmacol; 1975 Jan 15; 24(2):307-8. PubMed ID: 1111545
    [No Abstract] [Full Text] [Related]

  • 31. The homogeneity of pig brain mitochondrial monoamine oxidase.
    Tipton KF, Spires IP.
    Biochem Pharmacol; 1968 Oct 15; 17(10):2137-41. PubMed ID: 5696881
    [No Abstract] [Full Text] [Related]

  • 32. [On the effect of various digitalis substances on monoamine oxidase activity in rat, guinea pig and cat brain].
    Popov N, Förster W.
    Acta Biol Med Ger; 1966 Oct 15; 17(2):221-31. PubMed ID: 5983237
    [No Abstract] [Full Text] [Related]

  • 33. [Anti-monoamine-oxidase activity of some beta-acyl-phenylhydrazines].
    Arrigo Reina R, Mazzone G.
    Boll Soc Ital Biol Sper; 1970 Dec 30; 46(24):1041-4. PubMed ID: 5519865
    [No Abstract] [Full Text] [Related]

  • 34. Inhibition of monoamine oxidase from bovine retina by beta-carbolines.
    Fernández de Arriba A, Lizcano JM, Balsa MD, Unzeta M.
    J Pharm Pharmacol; 1994 Oct 30; 46(10):809-13. PubMed ID: 7699568
    [Abstract] [Full Text] [Related]

  • 35. Studies on the selective inhibition of membrane-bound rat liver monoamine oxidase.
    Mantle TJ, Wilson K, Long RF.
    Biochem Pharmacol; 1975 Nov 15; 24(22):2031-8. PubMed ID: 1212252
    [No Abstract] [Full Text] [Related]

  • 36. Carcinogenic tryptophan pyrolysis products potent inhibitors of type A monoamine oxidase and the platelet response to 5-hydroxytryptamine.
    Manabe S, Kanai Y, Ishikawa S, Wada O.
    J Clin Chem Clin Biochem; 1988 May 15; 26(5):265-70. PubMed ID: 3404091
    [Abstract] [Full Text] [Related]

  • 37. Studies on the monoamine oxidase of monkey brain.
    Oommen A, Balasubramanian AS.
    J Neurochem; 1977 Mar 15; 28(3):645-54. PubMed ID: 16088
    [No Abstract] [Full Text] [Related]

  • 38. Characteristics of brain and liver monoamine oxidase in a reptile, Anolis carolinensis.
    Kelley TD, Quay WB.
    Comp Gen Pharmacol; 1970 Sep 15; 1(3):323-35. PubMed ID: 5527568
    [No Abstract] [Full Text] [Related]

  • 39. Neurobiology of tetrahydro-beta-carbolines.
    Buckholtz NS.
    Life Sci; 1980 Sep 15; 27(11):893-903. PubMed ID: 6107810
    [No Abstract] [Full Text] [Related]

  • 40. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N, Barneoud P, Carter C, Caille D, Sontag N, Marc C, Lolivier J, Gardes A, Perron C, Le Kim A, Charieras T, Pandini M, Burnier P, Puech F, Jegham S, George P, Scatton B, Curet O.
    J Pharmacol Exp Ther; 2004 Sep 15; 310(3):1171-82. PubMed ID: 15178694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.